![Mark Evans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Evans
Presidente presso Obotritia Capital KGaA
Profilo
Mark Evans is currently the Chairman-Supervisory Board at Obotritia Capital KGaA and a Partner at Albemarle Life Sciences LLP.
Previously, he served as a Non-Independent Non-Executive Director at ReNeuron Group Plc from 2020 to 2022 and as a Partner at Taube Hodson Stonex Partners LLP from 1998 to 2016.
He obtained his undergraduate degree from the University of Bristol.
Posizioni attive di Mark Evans
Società | Posizione | Inizio |
---|---|---|
Obotritia Capital KGaA
![]() Obotritia Capital KGaA Real Estate DevelopmentFinance Obotritia Capital KGaA is a private investment firm that focuses on listed and unlisted markets. Its portfolio includes real estate, venture capital, and financial services. The company was founded by Rolf Elgeti on February 3, 2015 and is headquartered in Potsdam, Germany. | Presidente | - |
Albemarle Life Sciences LLP | Corporate Officer/Principal | - |
Precedenti posizioni note di Mark Evans
Società | Posizione | Fine |
---|---|---|
RENEURON GROUP PLC | Direttore/Membro del Consiglio | 22/03/2022 |
Taube Hodson Stonex Partners LLP
![]() Taube Hodson Stonex Partners LLP Investment ManagersFinance Taube Hodson Stonex Partners LLP (THS) is the equity asset management subsidiary of GAM International Management Ltd., ultimately held by GAM Holding AG (SW: GAM, ADR: GMHLY) in Switzerland. Founded by Nils Taube, John Hodson and Cato Stonex in 1997, the firm is based in London and is a socially responsible investor which manages in-house funds that are open to investment by private, intermediaries and institutional investors. Their flagship is the International Growth and Value Fund. | Corporate Officer/Principal | 01/01/2016 |
Formazione di Mark Evans
University of Bristol | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
RENEURON GROUP PLC | Health Technology |
Aziende private | 3 |
---|---|
Obotritia Capital KGaA
![]() Obotritia Capital KGaA Real Estate DevelopmentFinance Obotritia Capital KGaA is a private investment firm that focuses on listed and unlisted markets. Its portfolio includes real estate, venture capital, and financial services. The company was founded by Rolf Elgeti on February 3, 2015 and is headquartered in Potsdam, Germany. | Finance |
Taube Hodson Stonex Partners LLP
![]() Taube Hodson Stonex Partners LLP Investment ManagersFinance Taube Hodson Stonex Partners LLP (THS) is the equity asset management subsidiary of GAM International Management Ltd., ultimately held by GAM Holding AG (SW: GAM, ADR: GMHLY) in Switzerland. Founded by Nils Taube, John Hodson and Cato Stonex in 1997, the firm is based in London and is a socially responsible investor which manages in-house funds that are open to investment by private, intermediaries and institutional investors. Their flagship is the International Growth and Value Fund. | Finance |
Albemarle Life Sciences LLP |
- Borsa valori
- Insiders
- Mark Evans